Showing results (1571-1580 of 1,943) with videos related to

Sort By:
Pageof 195
Lupus|May 28, 2015
A case of catastrophic antiphospholipid syndrome: first report with advanced cardiac imaging using MRIA N Rosenbaum, N S Anavekar, F C Ernste, et al.
American Journal of Human Genetics|July 1, 1981
Insights into the expression of ABH and Lewis antigens through human bone marrow transplantationR Oriol, J Le Pendu, R S Sparkes, et al.
Journal of Medicinal Chemistry|December 23, 2016
Development of Small Molecules with a Noncanonical Binding Mode to HIV-1 Trans Activation Response (TAR) RNAFardokht A Abulwerdi, Matthew D Shortridge, Joanna Sztuba-Solinska, et al.
Circulation|October 1, 1988
Fate of pulmonary artery after anatomic correction of simple transposition of great arteries in newborn infantsC Paillole, D Sidi, J Kachaner, et al.
Vox Sanguinis|January 1, 1987
Heterogeneity of anti-A and anti-B monoclonal reagents. Agglutination of some weak ABH erythrocyte variants and recognition of synthetic oligosaccharide and tissue antigensP Gane, J Vellayoudom, R Mollicone, et al.
Bioorganic & Medicinal Chemistry Letters|April 15, 2011
New monoterpene glycosides and phenolic compounds from Distylium racemosum and their inhibitory activity against ribonuclease HJeong Ah Kim, Seo Young Yang, Anthony Wamiru, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 2004
Identification of an inhibitor-binding site to HIV-1 integrase with affinity acetylation and mass spectrometryNick Shkriabai, Sachindra S Patil, Sonja Hess, et al.
Nucleic Acids Research|October 10, 2015
Two distinct modes of metal ion binding in the nuclease active site of a viral DNA-packaging terminase: insight into the two-metal-ion catalytic mechanismHaiyan Zhao, Zihan Lin, Anna Y Lynn, et al.
Biochimie|January 1, 1986
Redox properties and activity studies on a nickel-containing hydrogenase isolated from a halophilic sulfate reducer Desulfovibrio salexigensM Teixeira, I Moura, G Fauque, et al.
European Journal of Immunology|June 8, 1999
The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28-mediated co-stimulationJ M Penninger, K D Fischer, T Sasaki, et al.
Pageof 195